TTR and amyloidosis: Despite the high prevalence of the TTR V142I variant in AA, there appears to be a substantial divergence between the number of TTR V142I carriers and diagnosed cases of ATTR-CM [8], suggesting that many patients, perhaps most, are undiagnosed, particularly those with heart failure who do not have overt clinical findings to suggest amyloidosis.